1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. COHANCE LIFESCIENCES LTD.

Cohance Lifesciences Ltd. NSE: SUVENPHAR | BSE: 543064

Cohance Lifesciences Ltd. Live Share Price Today, Share Analysis and Chart

Expensive Underperformer
about

Incorporated in 2018, Suven Pharmaceuticals is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract...

Read More

1079.20 21.00 (1.98%)

80.47% Gain from 52W Low

1.2M NSE+BSE Volume

High volume today

NSE 16 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
8.0 / 100
Momentum Score
Technically Bearish
32.5 / 100
Expensive Underperformer These stocks are medium in financial scores. They have bad valuation and technical scores as well. View Similar Embed DVM
Analyst Price Target
1,397
1Yr Price target upside is 29%
6 analysts

15

S

15

W

4

O

1

T

SWOT Analysis

Cohance Lifesciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

18 Feb, 2025 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Ea…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
12 Feb, 2025 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
pdf link
12 Feb, 2025 TRENDLYNE
Suven Pharmaceuticals Results Earnings Call for Q3FY25
Suven Pharmaceuticals Results Earnings Call for Q3FY25
video link
09 Dec, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
pdf link
17 Nov, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Ea…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
12 Nov, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
pdf link
12 Nov, 2024 TRENDLYNE
Suven Pharmaceuticals Results Earnings Call for Q2FY25
Suven Pharmaceuticals Results Earnings Call for Q2FY25
video link
14 Aug, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Ea…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
09 Aug, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
pdf link
09 Aug, 2024 TRENDLYNE
Suven Pharmaceuticals Results Earnings Call for Q1FY25
Suven Pharmaceuticals Results Earnings Call for Q1FY25
audio video link
19 Jun, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-An…
pdf link
19 Jun, 2024 TRENDLYNE
Suven Pharmaceuticals Business Update Call
Suven Pharmaceuticals Business Update Call
audio video link
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
27 Feb, 2025 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Long-term rating continues on 'Watch Positive'; Short-term rating reaffirmed
link
29 Nov, 2024 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Long-term rating continues on 'Watch Positive'; Short-term rating reaffirmed
link
04 Sep, 2024 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Long-term rating continues on 'Watch Positive'; Short-term rating reaffirmed
link
07 Jun, 2024 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Long-term rating continues on 'Watch Positive'; Short-term rating reaffirmed
link
11 Mar, 2024 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Long-term rating placed on 'Watch Positive'; short-term rating reaffirmed
link
26 Dec, 2023 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Ratings removed from \u2018Watch Developing\u2019; Ratings Reaffirmed
link
27 Sep, 2023 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Ratings continues on 'Watch Developing'
link
30 Jun, 2023 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Ratings continues on 'Watch Developing'
link
04 Apr, 2023 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Ratings continues on 'Watch Developing'
link
04 Jan, 2023 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Ratings placed on 'Watch Developing'
link
07 Apr, 2022 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Ratings upgraded to 'CRISIL A+/Stable/CRISIL A1+'
link
28 Jan, 2021 CRISIL RATINGS
Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited:Rated amount enhanced
link
All Credit Ratings
12 Feb, 2025 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
15 Jan, 2025 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
07 Dec, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
07 Dec, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Pr…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Pr…
pdf link
12 Nov, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
13 Jun, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
29 Feb, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
05 Feb, 2024 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
24 Nov, 2023 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
09 Nov, 2023 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
08 Aug, 2022 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link
09 May, 2022 BSE INDIA
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-In…
pdf link

Cohance Lifesciences Ltd. FAQ

How is Cohance Lifesciences Ltd. today?
Cohance Lifesciences Ltd. today is trading in the green, and is up by 1.98% at 1079.20.
Cohance Lifesciences Ltd. is currently trading up 1.98% on an intraday basis. In the past week the stock rose 0.13%. stock has been down -0.96% in the past quarter and rose 67.33% in the past year. You can view this in the overview section.